Thermo Fisher Scientific Inc.
TMO Healthcare Diagnostics & Research
Thermo Fisher Scientific Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.6 billion, up 3.91% from fiscal 2024. In the quarter to June 2026, revenue grew 10.5%, EPS grew 9.35%, free cash flow grew 51.8% and total debt rose 18.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
Follow TMO
Thermo Fisher Scientific Inc. (TMO) Return on assets
Thermo Fisher Scientific Inc.'s return on assets over the twelve months to 30 June 2026 was 6.50%, up 0.0 percentage points from fiscal 2025 (6.46%). Over the past ten years it has ranged from 4.34% (fiscal 2017) to 10.0% (fiscal 2020); the current reading is higher than 73% of that period. That is above the Diagnostics & Research industry median of −6.71% and above the Healthcare sector median of −30.9%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 6.46% | 0.00 |
| FY2024 | 6.46% | 0.34 |
| FY2023 | 6.12% | (1.11) |
| FY2022 | 7.23% | (2.18) |
| FY2021 | 9.41% | (0.60) |
| FY2020 | 10.0% | 3.56 |
| FY2019 | 6.45% | 1.25 |
| FY2018 | 5.20% | 0.86 |
| FY2017 | 4.34% | (0.32) |
| FY2016 | 4.66% | (0.06) |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| IDXX IDEXX Laboratories, Inc. compare | 33.7% |
| MTD Mettler-Toledo International, Inc. compare | 25.6% |
| ILMN Illumina, Inc. compare | 13.0% |
| A Agilent Technologies, Inc. compare | 11.0% |
| TMO Thermo Fisher Scientific Inc. | 6.50% |
| IQV IQVIA Holdings Inc. compare | 4.70% |
| DHR Danaher Corporation compare | 4.60% |
| WAT Waters Corporation compare | 1.13% |
| NTRA Natera, Inc. compare | −8.71% |
| Diagnostics & Research industry median | −6.71% |
| Healthcare sector median | −30.9% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on TMO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement